BridgeBio have significantly boosted the progress of an novel solution for ATTR-CM, utilizing the investigational drug. Preliminary trial data indicates significant benefits for those suffering with the severe https://attrcm290304.daneblogger.com/40758469/bridgebio-advances-cardiac-amyloidosis-therapy-through-the-drug